ValuEngine upgraded shares of Aquabounty Technologies (NASDAQ:AQB) from a hold rating to a buy rating in a research note issued to investors on Wednesday.
Several other research analysts also recently commented on AQB. HC Wainwright set a $4.00 price objective on Aquabounty Technologies and gave the stock a buy rating in a research note on Monday, September 17th. Zacks Investment Research raised Aquabounty Technologies from a sell rating to a hold rating in a research note on Thursday, September 13th.
AQB stock traded up $0.05 during trading on Wednesday, reaching $2.79. The stock had a trading volume of 520 shares, compared to its average volume of 68,225. Aquabounty Technologies has a 52 week low of $2.25 and a 52 week high of $9.99. The company has a debt-to-equity ratio of 0.14, a quick ratio of 3.30 and a current ratio of 0.98. The company has a market cap of $41.52 million, a price-to-earnings ratio of -2.61 and a beta of -0.68.
Aquabounty Technologies (NASDAQ:AQB) last posted its earnings results on Friday, November 2nd. The company reported ($0.21) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.01). The business had revenue of $0.01 million during the quarter, compared to the consensus estimate of $0.14 million. Equities analysts predict that Aquabounty Technologies will post -0.78 earnings per share for the current year.
A hedge fund recently raised its stake in Aquabounty Technologies stock. ARK Investment Management LLC increased its holdings in shares of Aquabounty Technologies Inc (NASDAQ:AQB) by 81.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 170,697 shares of the company’s stock after purchasing an additional 76,458 shares during the quarter. ARK Investment Management LLC owned approximately 1.33% of Aquabounty Technologies worth $568,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 62.48% of the company’s stock.
About Aquabounty Technologies
AquaBounty Technologies, Inc, a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc and changed its name to AquaBounty Technologies, Inc in June 2004.
Further Reading: How can investors find ex-dividend dates?
To view ValuEngine’s full report, visit ValuEngine’s official website.